Safety and dose‐dependency of eptacog beta (activated) in a dose escalation study of non‐bleeding congenital haemophilia A or B patients, with or without inhibitors
J. Ducore; J. B. Lawrence; M. Simpson; L. Boggio; A. Bellon; J. Burggraaf; J. Stevens; M. Moerland; J. Frieling; J. Reijers; M. Wang
Author Information: University of California
|Checking for direct PDF access through Ovid|
Abstract unavailable for this article.